A.I. Virtanen Institute for Molecular Sciences - News

Neurons produced from frontotemporal dementia patients’ skin biopsies using modern stem cell technology recapitulate the synaptic loss and dysfunction detected in the patients’ brains.

After TBI, some people develop epilepsy months or even years later. The doctoral research of Pedro Andrade, MSc, explores how and why this happens, using advanced brain monitoring techniques in animal models.

The widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections.

Polina Abushik, Anni Hartikainen, Soila Lemmetty, Iuliia Pilipenko, Isabell Rumrich, Atte Eskelinen and Henri Hyvönen were appointed to three-year UEF Research Fellow positions.

The University of Aveiro has joined the MIRACLE research project to develop more accurate and personalised methods for cardiovascular disease risk assessment, prevention, and treatment.

Rector Tapio Määttä has appointed the Heads and Deputy Heads of Departments and Schools of the faculties. The Head and Deputy Heads of UEF Law School was appointed by Vice Rector Jussi Pihlajamäki.

Tutkimus syventää ymmärrystä siitä, miten hypoksia vaikuttaa geenisäätelyyn sydän- ja verisuonisairauksissa, ja nostaa esiin KDM-entsyymit mahdollisina uusina lääkehoitojen kohteina.

Professor Tarja Malm has been awarded an ERC Proof of Concept Grant for the WAVEAD project focusing on the development of novel methods for measuring the electrical activity of the brain.

The Research Council of Finland’s Scientific Council for Biosciences, Health and the Environment has granted 6.6 million euros of funding to five new Academy Research Fellows, one Clinical Researcher and seven new Academy Projects.

“One absolutely can change their research topic after the PhD. Indeed, it is essential to adopt new perspectives and methods during the post-doc phase,” said Professor Christian Haass, speaking at the Neuroscience Research Community’s spring seminar in Kuopio.